CVRx, Inc. (CVRX)
NMS – Real vaqt narxi. Valyuta: USD
5.27
-1.65 (-23.84%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Find any stock by ticker or company name

NMS – Real vaqt narxi. Valyuta: USD
5.27
-1.65 (-23.84%)
Yopilishda: May 12, 2026, 4:00 PM EDT
CVRx, Inc., tijoriy bosqichdagi tibbiy qurilmalar kompaniyasi, Qo'shma Shtatlar, Germaniya va xalqaro miqyosda yurak-qon tomir kasalliklari bo'lgan bemorlar uchun neyromodulyatsiya yechimlarini ishlab chiqish, ishlab chiqarish va tijoratlashtirish bilan shug'ullanadi. Kompaniya Barostimni taklif etadi, bu implantatsiya qilinadigan qurilma bo'lib, u karotid arteriya devorida joylashgan baroreseptorlarga elektr impulslarini etkazib beradi, bu esa baroreseptor signallarining pasayishiga qarshi turadi va barorefleks aktivatsiya terapiyasini ta'minlaydi, bu esa yurak-qon tomir tizimini avtonom nerv sistemasiga bog'laydi. Mahsulotlarini to'g'ridan-to'g'ri sotish bo'limi, savdo agentlari va mustaqil distribyutorlar orqali sotadi. Kompaniya 2000 yilda tashkil etilgan va shtab-kvartirasi Minneapolis, Minnesota shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Philip B. Adamson M.D., M.Sc. | Chief Medical Officer |
| Mr. Brent Binkowski | Chief Operating Officer |
| Mr. Gregory Morrison | Chief Human Resources Officer |
| Mr. Jared Oasheim | Chief Financial Officer |
| Mr. Kevin Hykes | President, CEO & Director |
| Mr. Paul Verrastro | Chief Marketing & Strategy Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-12 | 10-Q | cvrx-20260331x10q.htm |
| 2026-05-11 | 8-K | tm2614163d1_8k.htm |
| 2026-04-20 | DEFA14A | ny20062360x2_defa14a.htm |
| 2026-04-13 | 8-K | tm2611335d1_8k.htm |
| 2026-03-03 | 8-K | tm267672d1_8k.htm |
| 2026-02-13 | 10-K | cvrx-20251231x10k.htm |
| 2026-02-12 | 8-K | tm266143d1_8k.htm |
| 2025-11-17 | DEL AM | tm2531452d1_delam.htm |
| 2025-11-06 | 10-Q | cvrx-20250930x10q.htm |
| 2025-11-05 | 8-K | tm2530302d1_8k.htm |
| Mr. Robert Allen John | Chief Revenue Officer |
| Ms. Bonnie Handke M.B.A., R.N. | Senior Vice President of Patient Access, Reimbursement, & Healthcare Economics |